Difficulty: Medium
Average Score: 79%
Practice
A 27-year-old woman is seen in clinic for ongoing management of her juvenile myoclonic epilepsy. Her seizures have been well controlled on lamotrigine, with no seizures in the past 2 years. She does report some symptoms of depression, as well as anticipatory anxiety regarding the possibility of future seizures. Which of the following options is the best next step in management?
Correct answer
B
Rationale
The correct next step in management for the 27-year-old woman with juvenile myoclonic epilepsy who is experiencing symptoms of depression and anticipatory anxiety is option B) citalopram. Citalopram is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. In this case, citalopram is appropriate as it can help alleviate the woman's depressive symptoms and anxiety without interfering with her seizure control provided by lamotrigine.
Option A) bupropion is not the best choice in this scenario because bupropion is contraindicated in patients with a history of seizures due to its potential to lower the seizure threshold, which could worsen the woman's epilepsy.
Option C) nortriptyline is a tricyclic antidepressant with anticholinergic effects that can lower the seizure threshold, making it a less suitable choice for a patient with epilepsy.
Option D) tapering off lamotrigine, the antiepileptic medication that has been effectively controlling her seizures, and starting levetiracetam is not recommended as it could increase the risk of breakthrough seizures and disrupt the woman's current seizure control.
Educationally, understanding the interactions between psychotropic medications and antiepileptic drugs is crucial for healthcare providers managing patients with epilepsy and comorbid psychiatric conditions. It is important to consider the patient's overall health, medication interactions, and individual needs when making treatment decisions to ensure optimal outcomes and quality of life.
Option A) bupropion is not the best choice in this scenario because bupropion is contraindicated in patients with a history of seizures due to its potential to lower the seizure threshold, which could worsen the woman's epilepsy.
Option C) nortriptyline is a tricyclic antidepressant with anticholinergic effects that can lower the seizure threshold, making it a less suitable choice for a patient with epilepsy.
Option D) tapering off lamotrigine, the antiepileptic medication that has been effectively controlling her seizures, and starting levetiracetam is not recommended as it could increase the risk of breakthrough seizures and disrupt the woman's current seizure control.
Educationally, understanding the interactions between psychotropic medications and antiepileptic drugs is crucial for healthcare providers managing patients with epilepsy and comorbid psychiatric conditions. It is important to consider the patient's overall health, medication interactions, and individual needs when making treatment decisions to ensure optimal outcomes and quality of life.